Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate
Top Cited Papers
Open Access
- 15 October 2002
- journal article
- research article
- Published by Wiley in Developmental Dynamics
- Vol. 225 (3) , 351-357
- https://doi.org/10.1002/dvdy.10163
Abstract
Early during development, one of the first indications that lymphangiogenesis has begun is the polarized expression of the homeobox gene Prox1 in a subpopulation of venous endothelial cells. It has been shown previously that Prox1 expression in the cardinal vein promotes and maintains the budding of endothelial cells that will form the lymphatic vascular system. Prox1‐deficient mice are devoid of lymphatic vasculature, and in these animals endothelial cells fail to acquire the lymphatic phenotype; instead, they remain as blood vascular endothelium. To investigate whether Prox1 is sufficient to induce a lymphatic fate in blood vascular endothelium, Prox1 cDNA was ectopically expressed by adenoviral gene transfer in primary human blood vascular endothelial cells and by transient plasmid cDNA transfection in immortalized microvascular endothelial cells. Transcriptional profiling combined with quantitative real‐time reverse transcription‐polymerase chain reaction and Western blotting analyses revealed that Prox1 expression up‐regulated the lymphatic endothelial cell markers podoplanin and vascular endothelial growth factor receptor‐3. Conversely, genes such as laminin, vascular endothelial growth factor‐C, neuropilin‐1, and intercellular adhesion molecule‐1, whose expression has been associated with the blood vascular endothelial cell phenotype, were down‐regulated. These results were confirmed by the use of specific antibodies against some of these markers in sections of embryonic and adult tissues. These findings validate our previous proposal that Prox1 is a key player in the molecular pathway leading to the formation of lymphatic vasculature and identify Prox1 as a master switch in the program specifying lymphatic endothelial cell fate. That a single gene product was sufficient to re‐program the blood vascular endothelium toward a lymphatic phenotype corroborates the close relationship between these two vascular systems and also suggests that during evolution, the lymphatic vasculature originated from the blood vasculature by the additional expression of only a few gene products such as Prox1.Keywords
This publication has 24 references indexed in Scilit:
- Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma GrowthPublished by Elsevier ,2002
- Molecular mechanisms of lymphangiogenesis in health and diseaseCancer Cell, 2002
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular developmentGenes & Development, 1999
- LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for HyaluronanThe Journal of cell biology, 1999
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999
- Increased Microvascular Density and Enhanced Leukocyte Rolling and Adhesion in the Skin of VEGF Transgenic MiceJournal of Investigative Dermatology, 1998
- A simplified system for generating recombinant adenovirusesProceedings of the National Academy of Sciences, 1998
- Prospero is a panneural transcription factor that modulates homeodomain protein activityProceedings of the National Academy of Sciences, 1997
- A new approach for identification of rat lymphatic capillaries using a monoclonal antibody.Archives of Histology and Cytology, 1990